Intravascular imaging technology developer Avinger reported a slight gain in revenue in the company's first quarter of 2019.
Revenue totaled $1.8 million in the first quarter, 2% above revenue in the first quarter of 2018. Half of the first quarter revenue -- $900,000 -- came from Avinger's Pantheris small vessel image-guided atherectomy system. The company's net loss was $5.1 million, compared with a net loss of $10.3 million in the first quarter of 2018.
In the financial report, Jeff Soinski, Avinger's president and CEO, said Pantheris "has the potential to expand our addressable market by as much as 50%, or an additional $180 million."
